Jay V. Patankar
- Biochemistry top 5%
- Lipid metabolism and biosynthesis 5
- Gastroenterology top 10%
- Pharmacology top 10%
-
- Inflammasome and immune disorders 4
- Cell death mechanisms and regulation 3
- Peroxisome Proliferator-Activated Receptors 3
-
- Cholesterol and Lipid Metabolism 7
-
- Liver Disease Diagnosis and Treatment 6
-
- Diet, Metabolism, and Disease 5
-
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Christoph BeckerDagmar KratkySascha ObrowskySanja Levak‐FrankAlbert K. GroenVinay SachdevGerald HöeflerMichael R. Hayden
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Jay V. Patankar
34 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Biochemistry 89
- Immunology 192
- Gastroenterology 47
- Pharmacology 68
- Molecular Biology 513
Countries citing papers authored by Jay V. Patankar
This map shows the geographic impact of Jay V. Patankar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay V. Patankar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay V. Patankar more than expected).
Fields of papers citing papers by Jay V. Patankar
This network shows the impact of papers produced by Jay V. Patankar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay V. Patankar. The network helps show where Jay V. Patankar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay V. Patankar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 7 | |
| 8 | Cell death in the gut epithelium and implications for chronic inflammationbreakdown → | 2020 | 283 |
| 9 | 2019 | 55 | |
| 10 | 2016 | 19 | |
| 11 | 2016 | 40 | |
| 12 | 2015 | 15 | |
| 13 | 2015 | 100 | |
| 14 | 2014 | 86 | |
| 15 | 2014 | 20 | |
| 16 | 2013 | 42 | |
| 17 | 2013 | 22 | |
| 18 | 2012 | 17 | |
| 19 | 2012 | 11 | |
| 20 | 2011 | 19 |
About Jay V. Patankar
Jay V. Patankar is a scholar working on Biochemistry, Gastroenterology and Endocrinology, Diabetes and Metabolism, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Diet, Metabolism, and Disease (5 papers), Lipid metabolism and biosynthesis (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Inflammasome and immune disorders (4 papers), Cell death mechanisms and regulation (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Biochemistry (89 citations), Immunology (192 citations) and Gastroenterology (47 citations). Jay V. Patankar has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Christoph Becker, Dagmar Kratky, Sascha Obrowsky, Sanja Levak‐Frank, Albert K. Groen, Vinay Sachdev, Gerald Höefler, Michael R. Hayden, Prakash G. Chandak and Roshni R. Singaraja. Their work appears in journals such as PLoS ONE, Diabetes and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.